SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 888.00
-27.00 (-2.95%)
At close: Nov 10, 2025
SUSMED,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
Cash & Equivalents | 4,167 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 | Upgrade |
Cash & Short-Term Investments | 4,167 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 | Upgrade |
Cash Growth | -11.02% | -9.25% | -4.00% | 2.94% | 201.60% | 344.26% | Upgrade |
Accounts Receivable | 15 | 15 | 10 | 10 | 9 | 5 | Upgrade |
Other Receivables | - | - | 9 | - | - | 11 | Upgrade |
Receivables | 15 | 15 | 19 | 10 | 9 | 16 | Upgrade |
Prepaid Expenses | 58 | 47 | 30 | 25 | 21 | 26 | Upgrade |
Other Current Assets | 5 | 2 | 3 | 2 | 1 | 6 | Upgrade |
Total Current Assets | 4,246 | 4,462 | 4,898 | 5,085 | 4,935 | 1,674 | Upgrade |
Long-Term Investments | 90 | 24 | 25 | 8 | 8 | - | Upgrade |
Other Intangible Assets | 40 | 16 | 8 | 7 | - | - | Upgrade |
Other Long-Term Assets | - | - | 1 | 1 | - | - | Upgrade |
Total Assets | 4,376 | 4,502 | 4,932 | 5,101 | 4,943 | 1,674 | Upgrade |
Accounts Payable | - | 1 | - | - | - | - | Upgrade |
Accrued Expenses | 2 | 1 | 1 | 1 | 1 | - | Upgrade |
Current Income Taxes Payable | 70 | 71 | 67 | 82 | 70 | 81 | Upgrade |
Current Unearned Revenue | - | - | - | - | - | 6 | Upgrade |
Other Current Liabilities | 49 | 52 | 253 | 141 | 16 | 9 | Upgrade |
Total Current Liabilities | 121 | 125 | 321 | 224 | 87 | 96 | Upgrade |
Other Long-Term Liabilities | 1 | 7 | 7 | 7 | 6 | 1 | Upgrade |
Total Liabilities | 122 | 132 | 328 | 231 | 93 | 97 | Upgrade |
Common Stock | 99 | 99 | 80 | 40 | 1,853 | 100 | Upgrade |
Additional Paid-In Capital | 5,441 | 5,441 | 5,423 | 5,383 | 3,509 | 1,756 | Upgrade |
Retained Earnings | -1,339 | -1,218 | -920 | -562 | -511 | -278 | Upgrade |
Comprehensive Income & Other | 53 | 48 | 21 | 9 | -1 | -1 | Upgrade |
Shareholders' Equity | 4,254 | 4,370 | 4,604 | 4,870 | 4,850 | 1,577 | Upgrade |
Total Liabilities & Equity | 4,376 | 4,502 | 4,932 | 5,101 | 4,943 | 1,674 | Upgrade |
Net Cash (Debt) | 4,167 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 | Upgrade |
Net Cash Growth | -11.02% | -9.25% | -4.00% | 2.94% | 201.60% | 344.26% | Upgrade |
Net Cash Per Share | 247.93 | 261.90 | 290.30 | 307.76 | 333.99 | 127.09 | Upgrade |
Filing Date Shares Outstanding | 16.82 | 16.81 | 16.74 | 16.55 | 16.11 | 12.79 | Upgrade |
Total Common Shares Outstanding | 16.82 | 16.81 | 16.74 | 16.55 | 16.11 | 12.79 | Upgrade |
Working Capital | 4,125 | 4,337 | 4,577 | 4,861 | 4,848 | 1,578 | Upgrade |
Book Value Per Share | 252.97 | 259.94 | 275.06 | 294.25 | 301.11 | 123.26 | Upgrade |
Tangible Book Value | 4,214 | 4,354 | 4,596 | 4,863 | 4,850 | 1,577 | Upgrade |
Tangible Book Value Per Share | 250.59 | 258.98 | 274.58 | 293.83 | 301.11 | 123.26 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.